The aim of this study is to determine if ultraviolet light (UVC) irradiation in combination with fluorescence-guided surgery (FGS) can eradicate metastatic human pancreatic cancer in orthotopic nude–mouse models. Two weeks after orthotopic implantation of human MiaPaCa-2 pancreatic cancer cells, expressing green fluorescent protein (GFP), in nude mice, bright-light surgery (BLS) was performed on all tumor-bearing mice (n = 24). After BLS, mice were randomized into 3 treatment groups; BLS-only (n = 8) or FGS (n = 8) or FGS-UVC (n = 8). The residual tumors were resected using a hand-held portable imaging system under fluorescence navigation in mice treated with FGS and FGS-UVC. The surgical resection bed was irradiated with 2700 J/m2 UVC (254 nm) in the mice treated with FGS-UVC. The average residual tumor area after FGS (n = 16) was significantly smaller than after BLS only (n = 24) (0.135±0.137 mm2 and 3.338±2.929 mm2, respectively; p = 0.007). The BLS treated mice had significantly reduced survival compared to FGS- and FGS-UVC-treated mice for both relapse-free survival (RFS) (p<0.001 and p<0.001, respectively) and overall survival (OS) (p<0.001 and p<0.001, respectively). FGS-UVC-treated mice had increased RFS and OS compared to FGS-only treated mice (p = 0.008 and p = 0.025, respectively); with RFS lasting at least 150 days indicating the animals were cured. The results of the present study suggest that UVC irradiation in combination with FGS has clinical potential to increase survival.
References
[1]
Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, et al. (2009) Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 38: 605–612.
[2]
Bouvet M, Hoffman RM (2011) Glowing tumors make for better detection and resection. Sci Transl Med 3: 110fs110.
[3]
Kaushal S, McElroy MK, Luiken GA, Talamini MA, Moossa RA, et al. (2008) Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 12: 1938–1950.
[4]
McElroy M, Kaushal S, Luiken GA, Talamini MA, Moossa AR, et al. (2008) Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation. World J Surg 32: 1057–1066.
[5]
Metildi CA, Kaushal S, Hardamon CR, Snyder CS, Pu M, et al. (2012) Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models. J Am Coll Surg 215: 126–135.
[6]
Kimura H, Lee S, Hayashi K, Yamauchi K, Yamamoto N, et al. (2010) UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 110: 1439–1446.
[7]
Miwa S, Yano S, Hiroshima S, Tome Y, Uehara F, et al. (2013) Imaging UVC-induced DNA damage response in models of minimal cancer. J Cell Biochem 114: 2493–2499.
[8]
Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R, et al. (2012) Fluorescent proteins enhance UVC PDT of cancer cells. Anticancer Res 32: 4327–4330.
[9]
Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R, et al. (2013) Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. J Cell Biochem 114: 428–434.
[10]
Tsai MH, Aki R, Amoh Y, Hoffman RM, Katsuoka K, et al. (2010) GFP-fluorescence-guided UVC irradiation inhibits melanoma growth and angiogenesis in nude mice. Anticancer Res 30: 3291–3294.
[11]
Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, et al. (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113: 151–160.
[12]
Tran Cao HS, Bouvet M, Kaushal S, Keleman A, Romney E, et al. (2010) Metronomic gemcitabine in combination with Sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther 9: 2068–2078.
[13]
Hoffman RM, Yang M (2006) Subcellular imaging in the live mouse. Nat Protoc 1: 775–782.
[14]
Hoffman RM, Yang M (2006) Color-coded fluorescence imaging of tumor-host interactions. Nat Protoc 1: 928–935.
[15]
Hoffman RM, Yang M (2006) Whole-body imaging with fluorescent proteins. Nat Protoc 1: 1429–1438.
[16]
Bouvet M, Wang JW, Nardin SR, Nassirpour R, Yang M, et al. (2002) Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534–1540.
[17]
Fu X, Guadagni F, Hoffman RM (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89: 5645–5649.
[18]
Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM (1993) A novel “patient–like” treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 53: 3070–3072.
[19]
Hoffman RM (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343–359.
[20]
Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, et al. (2006) Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 66: 4208–4214.
[21]
Hiroshima Y, Maawy A, Sato S, Murakami T, Uehara F, et al.. (2013) Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice. J Surg Research, in press. DOI:10.1016/j.jss.2013.11.1083.
[22]
Kimura H, Momiyama M, Tomita K, Tsuchiya H, Hoffman RM (2010) Long-working-distance fluorescence microscope with high-numerical-aperture objectives for variable-magnification imaging in live mice from macro- to subcellular. J Biomed Optics 15: 066029.
[23]
Pantel K, Alix-Panabieres C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6: 339–351.
[24]
Furukawa T, Kubota T, Watanabe M, Kitajima M, Fu X, et al. (1993) Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer 53: 608–612.
[25]
Fu X, Guadagni F, Hoffman RM (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically from histologically intact patient specimens. Proc Natl Acad Sci USA 89: 5645–5649.
[26]
Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, et al. (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53: 1204–1208.
[27]
An Z, Jiang P, Wang X, Moossa AR, Hoffman RM (1999) Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis 17: 265–270.
[28]
Theodorescu D, Cornil I, Fernandez B, Kerbel RS (1990) Overexpression of normal and mutated forms of Hras induces orthotopic-bladder invasion in a human transitional cell carcinoma. Proc Natl Acad Sci USA 87: 9047–9051.
[29]
Fu X, Theodorescu D, Kerbel RS, Hoffman RM (1991) Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice. Int J Cancer 49: 938–939.
[30]
Kuo TH, Kubota T, Watanabe M, Furukawa T, Kase S, et al. (1993) Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 13: 627–630.
[31]
Kishimoto H, Urata Y, Tanaka N, Fujiwara T, Hoffman RM (2009) Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol Cancer Ther 8: 3001–3008.
[32]
Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, et al. (2009) In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci USA 106: 14514–14517.
[33]
Kishimoto H, Aki R, Urata Y, Bouvet M, Momiyama M, et al. (2011) Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle 10: 2737–2741.
[34]
Metildi CA, Kaushal S, Lee C, Hardamon CR, Snyder CS, et al. (2012) An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models. J Am Coll Surg 214: 997–1007.
[35]
Metildi CA, Kaushal S, Snyder CS, Hoffman RM, Bouvet M (2013) Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model. J Surg Res 179: 87–93.
[36]
Tran Cao HS, Kaushal S, Metildi CA, Menen RS, Lee S, et al. (2012) Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology 59: 994–1999.
[37]
Metildi CA, Kaushal S, Pu M, Messer KA, Luiken GA, et al. (2014) Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer. Ann Surg Oncol 21: 1405–1411.
